Mark Strobeck
CIK 1599219 · President and CEO · last filed 2026-04-17
Mark Strobeck is a President and CEO who has filed 43 SEC Form 4 insider transactions across 4 companies since 2014. The most recent filing, for RMTI, was dated Apr 17, 2026. Across all open-market trades the lifetime net is −$989.0K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $6.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$6.04M
4
43
-$989.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RMTI | President and CEO | 323,493 | $0.62 | $202.1K | -$39.5K | 14 | 2026-04-17 |
| WINT | Director | 2,300 | $0.01 | $33 | $0 | 1 | 2023-08-25 |
| ASRT | EVP & Chief Operating Officer | 248,599 | $23.48 | $5.84M | $0 | 1 | 2020-05-22 |
| Zyla Life Sciences (EGLT) Delisted | Chief Operating Officer | 317,080 | — | — | -$949.5K | 21 | 2018-06-15 |
Recent Filings
43 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-17 | RMTI | Grant (A) | — | $0 | EDGAR |
| 2026-03-16 | RMTI | Tax (F) | −7,333 | -$6.6K | EDGAR |
| 2025-10-01 | RMTI | Sell (S) | −6,926 | -$8.2K | EDGAR |
| 2025-07-03 | RMTI | Sell (S) | −6,926 | -$5.7K | EDGAR |
| 2025-07-02 | RMTI | Sell (S) | −6,926 | -$5.7K | EDGAR |
| 2025-05-21 | RMTI | Grant (A) | +220,000 | $0 | EDGAR |
| 2025-04-02 | RMTI | Sell (S) | −6,926 | -$7.5K | EDGAR |
| 2025-03-18 | RMTI | Tax (F) | −13,434 | -$23.3K | EDGAR |
| 2025-01-06 | RMTI | Sell (S) | −2,163 | -$4.4K | EDGAR |
| 2024-10-02 | RMTI | Sell (S) | −2,163 | -$8.0K | EDGAR |